Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Circulating miRNAs expression profiling in drug-resistant epilepsy: Up-regulation of miR-301a-3p in a case of sudden unexpected death.

De Matteis M, Cecchetto G, Munari G, Balsamo L, Paola Gardiman M, Giordano R, Viel G, Fassan M.

Leg Med (Tokyo). 2018 Apr 18;33:5. doi: 10.1016/j.legalmed.2018.04.004. [Epub ahead of print] No abstract available.

PMID:
29689454
2.

Circulating miRNAs expression profiling in drug-resistant epilepsy: Up-regulation of miR-301a-3p in a case of sudden unexpected death.

De Matteis M, Cecchetto G, Munari G, Balsamo L, Gardiman MP, Giordano R, Viel G, Fassan M.

Leg Med (Tokyo). 2018 Mar;31:7-9. doi: 10.1016/j.legalmed.2017.12.003. Epub 2017 Dec 6.

PMID:
29220722
3.

Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN.

Xia X, Zhang K, Luo G, Cen G, Cao J, Huang K, Qiu Z.

Am J Transl Res. 2017 Apr 15;9(4):1886-1895. eCollection 2017.

4.

MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus.

Hu K, Xie YY, Zhang C, Ouyang DS, Long HY, Sun DN, Long LL, Feng L, Li Y, Xiao B.

BMC Neurosci. 2012 Sep 22;13:115. doi: 10.1186/1471-2202-13-115.

5.

MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.

Xia X, Zhang K, Cen G, Jiang T, Cao J, Huang K, Huang C, Zhao Q, Qiu Z.

Oncotarget. 2015 Aug 28;6(25):21046-63.

6.

SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients.

Haenisch S, Zhao Y, Chhibber A, Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK, Lowenstein DH, Cascorbi I, Kroetz DL.

Neurobiol Dis. 2015 May;77:127-40. doi: 10.1016/j.nbd.2015.02.025. Epub 2015 Mar 10.

7.

Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4.

Lu Y, Gao W, Zhang C, Wen S, Huangfu H, Kang J, Wang B.

J Cancer. 2015 Oct 20;6(12):1260-75. doi: 10.7150/jca.12659. eCollection 2015.

8.

Overexpression of miR-130a-3p/301a-3p attenuates high glucose-induced MPC5 podocyte dysfunction through suppression of TNF-α signaling.

Jiang Y, Wang W, Liu ZY, Xie Y, Qian Y, Cai XN.

Exp Ther Med. 2018 Jan;15(1):1021-1028. doi: 10.3892/etm.2017.5465. Epub 2017 Nov 8.

9.

Differential microRNA expression following infection with a mouse-adapted, highly virulent avian H5N2 virus.

Choi EJ, Kim HB, Baek YH, Kim EH, Pascua PN, Park SJ, Kwon HI, Lim GJ, Kim S, Kim YI, Choi YK.

BMC Microbiol. 2014 Sep 30;14:252. doi: 10.1186/s12866-014-0252-0.

10.

Expression of microRNA-129-2-3p and microRNA-935 in plasma and brain tissue of human refractory epilepsy.

Sun Y, Wang X, Wang Z, Zhang Y, Che N, Luo X, Tan Z, Sun X, Li X, Yang K, Wang G, Luan L, Liu Y, Zheng X, Wei M, Cheng H, Yin J.

Epilepsy Res. 2016 Nov;127:276-283. doi: 10.1016/j.eplepsyres.2016.09.016. Epub 2016 Sep 23.

PMID:
27689807
11.

MiR-466b-1-3p regulates P-glycoprotein expression in rat cerebral microvascular endothelial cells.

Yang X, Ren W, Shao Y, Chen Y.

Neurosci Lett. 2017 Apr 3;645:60-66. doi: 10.1016/j.neulet.2017.02.044. Epub 2017 Feb 22.

PMID:
28235604
12.

CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.

Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S.

Genes Chromosomes Cancer. 2009 Jul;48(7):615-23. doi: 10.1002/gcc.20669.

PMID:
19396864
13.

Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer.

Dinh TK, Fendler W, Chałubińska-Fendler J, Acharya SS, O'Leary C, Deraska PV, D'Andrea AD, Chowdhury D, Kozono D.

Radiat Oncol. 2016 Apr 27;11:61. doi: 10.1186/s13014-016-0636-4.

14.

Profiling the circulating miRNAs in mice exposed to gram-positive and gram-negative bacteria by Illumina small RNA deep sequencing.

Rau CS, Wu SC, Yang JC, Lu TH, Wu YC, Chen YC, Tzeng SL, Wu CJ, Hsieh CH.

J Biomed Sci. 2015 Jan 7;22:1. doi: 10.1186/s12929-014-0106-y.

15.

MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.

Zhang Y, Duan G, Feng S.

Biochem Biophys Res Commun. 2015 Apr 10;459(3):367-73. doi: 10.1016/j.bbrc.2015.02.101. Epub 2015 Feb 26.

PMID:
25727016
16.

Circulating microRNAs as biomarkers in progressive multiple sclerosis.

Vistbakka J, Elovaara I, Lehtimäki T, Hagman S.

Mult Scler. 2017 Mar;23(3):403-412. doi: 10.1177/1352458516651141. Epub 2016 Jul 11.

PMID:
27246141
17.

MicroRNA profiling in the dentate gyrus in epileptic rats: The role of miR-187-3p.

Zhang S, Kou Y, Hu C, Han Y.

Medicine (Baltimore). 2017 Jun;96(22):e6744. doi: 10.1097/MD.0000000000006744.

18.

Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.

Bowden M, Zhou CW, Zhang S, Brais L, Rossi A, Naudin L, Thiagalingam A, Sicinska E, Kulke MH.

Oncotarget. 2017 Apr 7;8(33):54331-54344. doi: 10.18632/oncotarget.16908. eCollection 2017 Aug 15.

19.

The expression and role of miR-301a in human umbilical cord-derived mesenchymal stromal cells.

Ma F, Chen D, Chi Y, Chen F, Li X, Han Z.

Cytotherapy. 2013 Dec;15(12):1511-6. doi: 10.1016/j.jcyt.2013.06.007. Epub 2013 Sep 10.

PMID:
24035358
20.

Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.

Juzėnas S, Saltenienė V, Kupcinskas J, Link A, Kiudelis G, Jonaitis L, Jarmalaite S, Kupcinskas L, Malfertheiner P, Skieceviciene J.

PLoS One. 2015 Jul 14;10(7):e0132327. doi: 10.1371/journal.pone.0132327. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0135762.

Supplemental Content

Support Center